OMI Stock Fair Value – Owens & Minor Unveils New Strategic Vision at Investor Day

December 7, 2023

☀️Trending News

At their recent Investor Day, Owens & Minor ($NYSE:OMI), a leading national distributor of medical and surgical supplies to the healthcare industry, revealed their new long-term strategic vision. The company’s mission is to reduce its customers’ total cost of care while improving service and product quality. The new strategy includes a renewed focus on customer service and portfolio diversification, with the goal of increasing profitable growth and delivering superior returns. Its stock is publicly traded on the New York Stock Exchange under the symbol OMI.

The company offers a wide range of products and services to hospitals, clinics, and long-term care facilities, as well as distributors, manufacturers, and group purchasing organizations. Owens & Minor also provides technology solutions to help healthcare providers manage costs and operations.

Price History

On Wednesday, Owens & Minor, the leading healthcare services provider, unveiled its new strategic vision at its Investor Day event. At the opening of the market, the stock opened at $22.1 and closed at $22.2, up by 1.5% from last closing price of 21.8. The new strategic vision focuses on improving operational efficiencies and capitalizing on the company’s core strengths in distributing and delivering medical and surgical supplies to the healthcare industry in the U.S. and abroad.

The company expects the new strategy to enable it to improve customer service levels, accelerate its supply chain capabilities, and create long-term value for shareholders. The company remains committed to its mission of providing quality services and products to healthcare providers worldwide. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for OMI. More…

    Total Revenues Net Income Net Margin
    10.23k -117.08 -0.5%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for OMI. More…

    Operations Investing Financing
    715.91 -131.11 -429.6
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for OMI. More…

    Total Assets Total Liabilities Book Value Per Share
    5.12k 4.24k 11.59
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for OMI are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    7.2% -16.9% -0.1%
    FCF Margin ROE ROA
    5.0% -0.6% -0.1%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis – OMI Stock Fair Value

    GoodWhale has conducted an analysis of OWENS & MINOR’s financials and our proprietary Valuation Line shows that the fair value of their share is around $30.5. This indicates that OWENS & MINOR’s stock is currently trading at $22.2, which is 27.1% undervalued. We believe this presents an interesting opportunity for potential investors and should be considered carefully. More…

  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    Owens & Minor Inc is in the business of distributing medical supplies and providing related services to healthcare providers. The company operates in North America and Europe. Its competitors include Orthofix Medical Inc, Medirect Latino Inc, PT Millennium Pharmacon International Tbk.

    – Orthofix Medical Inc ($NASDAQ:OFIX)

    Orthofix Medical Inc is a medical device company that provides orthopedic solutions to patients worldwide. The company has a market cap of 297.51M as of 2022 and a Return on Equity of -4.8%. The company’s products are used in the treatment of various conditions, including osteoarthritis, degenerative disc disease, scoliosis, and deformities. The company’s products are sold through a network of distributors and retailers.

    – Medirect Latino Inc ($OTCPK:MLTO)

    PT Millennium Pharmacon International Tbk is a leading pharmaceutical company in Indonesia with a market cap of 156.7B as of 2022. The company has a strong focus on research and development, and has a strong portfolio of products. The company has a Return on Equity of 17.77%.

    Summary

    At Owens & Minor’s recent Investor Day, the company unveiled their long-term strategy that focuses on reducing costs, streamlining operations, and investing in new technology. They aim to create value for shareholders by driving down expenses, optimizing supply chain networks, and leveraging new innovations. Owens & Minor plans to focus on expanded services, product integration, and better customer engagement to increase growth.

    They will also invest in technology that provides visibility into operations and demand management capabilities. Overall, their long-term strategy is designed to improve operational efficiency while providing customers with enhanced solutions.

    Recent Posts

    Leave a Comment